Bo Jiao
Impact in
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Pharmaceutical Science top 5%
- Chemical Reactions and Isotopes
Papers in
-
- Protein Kinase Regulation and GTPase Signaling 5
- Epigenetics and DNA Methylation 5
- Hematology 11
- Acute Myeloid Leukemia Research 6
- Chronic Myeloid Leukemia Treatments 5
- Co-authors
- Ruibao Ren (21 shared papers)Yaoqiu Zhu (2 shared papers)Jiang Zhou (1 shared paper)Ping Liu (14 shared papers)Xiufei Chen (2 shared papers)Hui Yang (1 shared paper)Huaipeng Lin (2 shared papers)Yanping Xu (1 shared paper)
- Journals
- Blood (4 papers)Frontiers of Medicine (3 papers)Chinese Chemical Letters (3 papers)BioScience Trends (3 papers)Journal of Hematology & Oncology (2 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Bo Jiao
53 papers receiving 914 citations
Peers
Comparison fields: 5 of 107
- Hematology 208
- Pharmaceutical Science 62
- Molecular Biology 482
- Cancer Research 84
- Genetics 44
Countries citing papers authored by Bo Jiao
This map shows the geographic impact of Bo Jiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Jiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Jiao more than expected).
Fields of papers citing papers by Bo Jiao
This network shows the impact of papers produced by Bo Jiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Jiao. The network helps show where Bo Jiao may publish in the future.
Co-authors
The 25 scholars most cited alongside Bo Jiao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 59 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 233 | |
| 2 | 2013 | 74 | |
| 3 | 2009 | 60 | |
| 4 | 2021 | 55 | |
| 5 | 2012 | 53 | |
| 6 | 2012 | 49 | |
| 7 | 2010 | 39 | |
| 8 | 2011 | 30 | |
| 9 | 2021 | 25 | |
| 10 | 2015 | 21 | |
| 11 | 2020 | 20 | |
| 12 | 2009 | 17 | |
| 13 | 2013 | 15 | |
| 14 | 2020 | 15 | |
| 15 | 2016 | 14 | |
| 16 | 2024 | 13 | |
| 17 | 2010 | 13 | |
| 18 | 2010 | 13 | |
| 19 | 2010 | 13 | |
| 20 | 2013 | 12 |
About Bo Jiao
Bo Jiao is a scholar working on Molecular Biology, Hematology, Pathology and Forensic Medicine, Epidemiology and Immunology, having authored 59 papers that have together received 930 indexed citations. Recurring topics across this work include Pneumonia and Respiratory Infections (6 papers), Acute Myeloid Leukemia Research (6 papers), Protein Kinase Regulation and GTPase Signaling (5 papers), Epigenetics and DNA Methylation (5 papers), Chronic Myeloid Leukemia Treatments (5 papers), Antibiotic Resistance in Bacteria (4 papers), Acute Lymphoblastic Leukemia research (4 papers) and Cardiac Ischemia and Reperfusion (4 papers). The work is most often cited by research in Hematology (208 citations), Pharmaceutical Science (62 citations), Molecular Biology (482 citations), Cancer Research (84 citations) and Genetics (44 citations). Bo Jiao has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Ruibao Ren, Yaoqiu Zhu, Jiang Zhou, Ping Liu, Xiufei Chen, Hui Yang, Huaipeng Lin, Yanping Xu, Lei Lv and Mengtao Xiao. Their work appears in journals such as Blood, Frontiers of Medicine, Chinese Chemical Letters, BioScience Trends and Journal of Hematology & Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.